Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Current Ratio 2011-2024 | ZTS

Current and historical current ratio for Zoetis (ZTS) from 2011 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Zoetis current ratio for the three months ending June 30, 2024 was 3.45.
  
Zoetis Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-06-30 $6.20B $1.80B 3.45
2024-03-31 $6.36B $1.91B 3.33
2023-12-31 $6.34B $1.89B 3.36
2023-09-30 $6.22B $1.61B 3.87
2023-06-30 $6.18B $1.77B 3.50
2023-03-31 $6.27B $1.92B 3.27
2022-12-31 $7.51B $3.17B 2.37
2022-09-30 $6.55B $2.88B 2.28
2022-06-30 $6.65B $3.05B 2.18
2022-03-31 $6.84B $3.03B 2.25
2021-12-31 $6.93B $1.80B 3.86
2021-09-30 $6.68B $1.47B 4.54
2021-06-30 $7.05B $2.09B 3.37
2021-03-31 $6.79B $2.07B 3.29
2020-12-31 $6.61B $2.17B 3.05
2020-09-30 $6.76B $2.40B 2.82
2020-06-30 $6.29B $1.81B 3.47
2020-03-31 $4.77B $1.72B 2.77
2019-12-31 $4.75B $1.81B 2.63
2019-09-30 $4.62B $1.05B 4.39
2019-06-30 $4.48B $1.08B 4.17
2019-03-31 $4.38B $1.08B 4.05
2018-12-31 $4.40B $1.22B 3.60
2018-09-30 $4.08B $1.00B 4.06
2018-06-30 $4.24B $0.97B 4.38
2018-03-31 $4.27B $1.00B 4.27
2017-12-31 $4.22B $1.09B 3.86
2017-09-30 $4.89B $1.75B 2.80
2017-06-30 $3.58B $1.78B 2.01
2017-03-31 $3.38B $1.73B 1.96
2016-12-31 $3.39B $1.12B 3.04
2016-09-30 $3.36B $1.04B 3.24
2016-06-30 $3.33B $1.04B 3.20
2016-03-31 $3.31B $1.16B 2.84
2015-12-31 $3.83B $1.78B 2.15
2015-09-30 $3.45B $1.66B 2.08
2015-06-30 $3.32B $1.57B 2.11
2015-03-31 $3.11B $1.37B 2.27
2014-12-31 $3.47B $1.09B 3.19
2014-09-30 $3.35B $1.00B 3.36
2014-06-30 $3.33B $1.06B 3.14
2014-03-31 $3.22B $1.13B 2.86
2013-12-31 $3.36B $1.42B 2.37
2013-09-30 $3.08B $1.31B 2.36
2013-06-30 $3.08B $1.32B 2.33
2013-03-31 $2.94B $1.29B 2.29
2012-12-31 $2.86B $1.12B 2.55
2012-09-30 $0.00B 0.00
2012-06-30 $0.00B 0.00
2012-03-31 $0.00B 0.00
2011-12-31 $2.31B $0.84B 2.74
2010-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $79.017B $8.544B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $43.337B 9.02
Sandoz Group AG (SDZNY) Switzerland $19.524B 0.00
Merck (MKKGY) Germany $19.470B 17.44
Astellas Pharma (ALPMY) Japan $19.363B 17.83
United Therapeutics (UTHR) United States $16.217B 15.95
Summit Therapeutics (SMMT) United States $13.503B 0.00
Shionogi (SGIOY) Japan $12.119B 11.61
Neurocrine Biosciences (NBIX) United States $11.890B 31.49
Catalent (CTLT) United States $10.727B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.354B 7.19
Orion OYJ (ORINY) Finland $6.653B 18.71
Madrigal Pharmaceuticals (MDGL) United States $6.294B 0.00
Corcept Therapeutics (CORT) United States $5.431B 41.13
Ionis Pharmaceuticals (IONS) United States $5.422B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.075B 0.00
PTC Therapeutics (PTCT) United States $3.026B 0.00
Dyne Therapeutics (DYN) United States $2.889B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.622B 15.69
Catalyst Pharmaceuticals (CPRX) United States $2.457B 11.14
Arrowhead Pharmaceuticals (ARWR) United States $2.309B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.300B 0.00
Soleno Therapeutics (SLNO) United States $2.233B 0.00
Evotec AG (EVO) Germany $1.928B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.813B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.770B 0.00
Xencor (XNCR) United States $1.614B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.456B 0.00
Ocular Therapeutix (OCUL) United States $1.440B 0.00
Harrow (HROW) United States $1.389B 0.00
ARS Pharmaceuticals (SPRY) United States $1.362B 0.00
Indivior (INDV) United States $1.354B 5.52
Guardian Pharmacy Services (GRDN) United States $1.300B 0.00
Cassava Sciences (SAVA) United States $1.295B 0.00
Enliven Therapeutics (ELVN) United States $1.193B 0.00
Ardelyx (ARDX) United States $1.177B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.163B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.050B 0.00
Collegium Pharmaceutical (COLL) United States $0.954B 5.21
Bioventus (BVS) United States $0.912B 28.82
Relay Therapeutics (RLAY) United States $0.854B 0.00
USANA Health Sciences (USNA) United States $0.769B 14.25
Cronos Group (CRON) Canada $0.768B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.674B 0.00
Tourmaline Bio (TRML) United States $0.650B 0.00
Exscientia (EXAI) United Kingdom $0.613B 0.00
Elite Pharmaceuticals (ELTP) United States $0.600B 0.00
Altimmune (ALT) United States $0.541B 0.00
Organogenesis (ORGO) United States $0.512B 0.00
Savara (SVRA) United States $0.511B 0.00
ProKidney (PROK) United States $0.491B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.468B 0.00
Zevra Therapeutics (ZVRA) United States $0.460B 0.00
OmniAb (OABI) United States $0.458B 0.00
Korro Bio (KRRO) United States $0.446B 0.00
Xeris Biopharma Holdings (XERS) United States $0.435B 0.00
Larimar Therapeutics (LRMR) United States $0.427B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.425B 172.14
Siga Technologies (SIGA) United States $0.424B 4.95
Esperion Therapeutics (ESPR) United States $0.418B 0.00
KalVista Pharmaceuticals (KALV) United States $0.410B 0.00
4D Molecular Therapeutics (FDMT) United States $0.408B 0.00
Verve Therapeutics (VERV) United States $0.406B 0.00
Aquestive Therapeutics (AQST) United States $0.405B 0.00
Akebia Therapeutics (AKBA) United States $0.391B 0.00
Silence Therapeutics (SLN) United Kingdom $0.380B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.326B 0.00
Avita Medical (RCEL) United States $0.313B 0.00
Sage Therapeutics (SAGE) United States $0.312B 0.00
Lyell Immunopharma (LYEL) United States $0.307B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 17.58
Aldeyra Therapeutics (ALDX) United States $0.251B 0.00
Pyxis Oncology (PYXS) United States $0.249B 0.00
Lexeo Therapeutics (LXEO) United States $0.220B 0.00
Acrivon Therapeutics (ACRV) United States $0.217B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.202B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.202B 0.00
Profound Medical (PROF) Canada $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.197B 0.00
Nanobiotix S.A (NBTX) France $0.185B 0.00
Heron Therapeutics (HRTX) United States $0.181B 0.00
Galectin Therapeutics (GALT) United States $0.174B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
CytoDyn (CYDY) United States $0.148B 0.00
Aclaris Therapeutics (ACRS) United States $0.146B 0.00
Achieve Life Sciences (ACHV) Canada $0.146B 0.00
Context Therapeutics (CNTX) United States $0.138B 0.00
Avalo Therapeutics (AVTX) United States $0.129B 0.00
Incannex Healthcare (IXHL) Australia $0.127B 0.00
Telomir Pharmaceuticals (TELO) United States $0.110B 0.00
Journey Medical (DERM) United States $0.107B 0.00
Century Therapeutics (IPSC) United States $0.104B 0.00
VAXART, INC (VXRT) United States $0.103B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Karyopharm Therapeutics (KPTI) United States $0.102B 0.00
Fractyl Health (GUTS) United States $0.095B 0.00
Regulus Therapeutics (RGLS) United States $0.094B 0.00
Arch Biopartners (ACHFF) Canada $0.092B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
CASI Pharmaceuticals (CASI) China $0.082B 0.00
Vivani Medical (VANI) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.28
ESSA Pharma (EPIX) Canada $0.076B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 0.00
ElectroCore (ECOR) United States $0.072B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Scienture Holdings (SCNX) United States $0.069B 0.00
Metagenomi (MGX) United States $0.068B 0.00
AlloVir (ALVR) United States $0.066B 0.00
OptiNose (OPTN) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Mural Oncology (MURA) Ireland $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.057B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Protara Therapeutics (TARA) United States $0.051B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Unicycive Therapeutics (UNCY) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
Rafael Holdings (RFL) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.038B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Carisma Therapeutics (CARM) United States $0.037B 0.00
Citius Pharmaceuticals (CTXR) United States $0.036B 0.00
FibroGen (FGEN) United States $0.034B 0.00
DURECT (DRRX) United States $0.031B 0.00
BioVie (BIVI) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Oruka Therapeutics (ORKA) United States $0.029B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.027B 0.00
GlycoMimetics (GLYC) United States $0.027B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Tempest Therapeutics (TPST) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.018B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Conduit Pharmaceuticals (CDT) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
SHINECO (SISI) China $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Oncternal Therapeutics (ONCT) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
CERo Therapeutics Holdings (CERO) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 1.33
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 37.26